Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Álvaro Martínez Mesa"'
Autor:
Álvaro Martínez Mesa, Ana Maria Aguilar Alvarez, Esther Sanchez Alvarez, Eva Cabrera César, Lorena Piñel Jiménez, Nuria Reina Marfil
Publikováno v:
Pulmonary embolism.
Lung cancer is the one with the highest mortality in the developed world and one of the tumors with the greatest relationship with the development of pulmonary embolism(PE). We aim to analyze whether the histopathological differences are related to t
Publikováno v:
Respiratory infections and bronchiectasis.
Autor:
Javier Lopez Garcia, Eva Cabrera César, Jose Luis Velasco Garrido, Nuria Reina Marfil, Álvaro Martínez Mesa, Esther Sanchez Alvarez
Publikováno v:
Tobacco, smoking control and health education.
Autor:
Eva Cabrera César, Yanina S. Romero-Zerbo, Esther Sanchez Alvarez, Pilar Martinez Lopez, Jose Luis Velasco Garrido, Álvaro Martínez Mesa, María García-Fernández, Elisa Martín-Montañez
Publikováno v:
Antioxidants
Volume 10
Issue 8
Antioxidants, Vol 10, Iss 1221, p 1221 (2021)
Volume 10
Issue 8
Antioxidants, Vol 10, Iss 1221, p 1221 (2021)
Introduction: SARS-CoV-2 (COVID-19) patients who develop acute respiratory distress syndrome (ARDS) can suffer acute lung injury, or even death. Early identification of severe disease is essential in order to control COVID-19 and improve prognosis. O
Autor:
Esther Sanchez Alvarez, Álvaro Martínez Mesa, Ana Aguilar Galvez, Jose Luis Velasco Garrido, Nuria Reina Marfil, Eva Cabrera César
Publikováno v:
Tobacco, smoking control and health educ..
Autor:
María del Carmen Fernández Aguirre, Eva Cabrera César, Álvaro Martínez Mesa, Ana Aguilar Galvez, Esther Sanchez, Nuria Reina Marfil
Publikováno v:
Lung cancer.
Autor:
Nuria Reina Marfil, Esther Sanchez Alvarez, Eva Cabrera César, Álvaro Martínez Mesa, María del Carmen Fernández Aguirre, Ana Aguilar Galvez
Publikováno v:
Airway pharmacology and treatment.
Introduction: Severe asthma means asthma that is uncontrolled despite adherence with maximal optimized therapy and treatment of contributory factors, or that worsens when high dose treatment is decreased. Mepolizumab arises as an asthma treatment in
Autor:
Álvaro Martínez Mesa, Nuria Reina Marfil, María del Carmen Vera Sanchez, Ana Aguilar Galvez, Eva Cabrera César, Ester Sanchez Alvarez
Publikováno v:
Lung cancer.
Introduction: Personalized medicine is key to deciding the optimal treatment for a patient with lung cancer. In recent years, biomolecular markers have been discovered that have allowed increasing the therapeutic against lung cancer, especially in ad
Publikováno v:
Archivos de Bronconeumología (English Edition). 56:121-122
Publikováno v:
Archivos de Bronconeumología. 56:121-122